UnknownNCT06351514
An Open-Label, Single Arm Study of the Efficacy of Accelerated Intermittent Theta Burst Stimulation in Schizophrenia Patients With Persistent Negative Symptoms
Device studyAges 21–65Singapore
Understand this study
Who could participate?
This study is for people with schizophrenia. Listed age limits: 21 years to 65 years. Other eligibility criteria apply.
- Listed locations
- SingaporeSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 1, 2024
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 40
- Sponsor
- Institute of Mental Health, Singapore
- Sponsor type
- Research institute
- Study type
- Device
- Intervention type
- Device
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Singapore
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT06351514
- Official title
Show the full official title
An Open-Label, Single Arm Study of the Efficacy of Accelerated Intermittent Theta Burst Stimulation in Schizophrenia Patients With Persistent Negative Symptoms
Recruitment & locations
Status unknownThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Singapore
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Institute of Mental Health, Singapore, a research institute.
Who can participate?
This study is for people with schizophrenia. Listed age limits: 21 years to 65 years. Other eligibility criteria apply.
